Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 0.53 is 91% below its 5-year average of 5.73, near the low end of its 5-year range (0.53–13.91).
As of the fiscal period ended Tuesday, June 30, 2026. 79.79% below its 12-month average of 2.61.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.53.
CURRENT RATIO
0.53
CURRENT RATIO AVG TTM
2.61
CURRENT RATIO AVG 3Y
5.08
CURRENT RATIO AVG 5Y
5.73
CURRENT RATIO AVG 10Y
8.15
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-79.79%
CURRENT VS 3Y AVG
-89.61%
CURRENT VS 5Y AVG
-90.79%
CURRENT VS 10Y AVG
-93.52%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.76
median of 873 covered companies
CURRENT VS SECTOR MEDIAN
-85.96%
vs the sector median at left
Market Cap
$63.78M
Current Ratio
9.90
TTM Avg
11.46
3Y Avg
13.71
5Y Avg
15.39
Market Cap
$68.90M
Current Ratio
6.12
TTM Avg
4.89
3Y Avg
4.59
5Y Avg
6.09
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Gossamer Bio, Inc. (GOSS) | $65.87M | 0.53 | 2.61 | 5.08 | 5.73 |
| Cingulate Inc. (CING)vs › | $65.86M | 3.50 | 1.85 | 1.22 | 3.58 |
| XBiotech Inc. (XBIT)vs › | $65.85M | 33.15 | 13.79 | 28.68 | 44.67 |
| iBio, Inc. (IBIO)vs › | $67.52M | 7.85 | 4.72 | 3.68 | 5.33 |
| Alps Group Inc (ALPS)vs › | $64.18M | 0.36 | 0.31 | 0.29 | 1.05 |
| Pliant Therapeutics, Inc. (PLRX)vs › | $63.78M | 9.90 | 11.46 | 13.71 | 15.39 |
| Fortress Biotech, Inc. (FBIO)vs › | $68.10M | 3.96 | 1.88 | 1.73 | 2.58 |
| InterCure Ltd. (INCR)vs › | $63.02M | 1.48 | 1.60 | 1.69 | 1.84 |
| Spero Therapeutics, Inc. (SPRO)vs › | $68.90M | 6.12 | 4.89 | 4.59 | 6.09 |
| Heron Therapeutics, Inc. (HRTX)vs › | $62.78M | 2.49 | 2.38 | 2.41 | 2.71 |
Current Ratio
0.53
Quick Ratio
0.53
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 0.53 |
| 2026-03-31 | 2.20 |
| 2025-12-31 | 2.64 |
| 2025-09-30 | 3.28 |
| 2025-06-30 | 4.40 |
| 2025-03-31 | 5.71 |
| 2024-12-31 | 6.88 |
| 2024-09-30 | 6.74 |
| 2024-06-30 | 8.21 |
| 2024-03-31 | 7.13 |
| 2023-12-31 | 5.94 |
| 2023-09-30 | 8.07 |
| 2023-06-30 | 4.32 |
| 2023-03-31 | 5.19 |
| 2022-12-31 | 5.32 |
| 2022-09-30 | 5.93 |
| 2022-06-30 | 5.24 |
| 2022-03-31 | 8.12 |
| 2021-12-31 | 8.32 |
| 2021-09-30 | 10.42 |
| 2021-06-30 | 13.91 |
| 2021-03-31 | 15.82 |
| 2020-12-31 | 13.51 |
| 2020-09-30 | 17.36 |
| 2020-06-30 | 22.09 |
| 2020-03-31 | 12.53 |
| 2019-12-31 | 11.09 |
| 2019-09-30 | 13.64 |
| 2019-06-30 | 17.80 |
| 2019-03-31 | 19.79 |
| 2018-12-31 | 11.37 |
| 2018-09-30 | 17.29 |
| 2018-06-30 | 8.47 |
| 2018-03-31 | 0.00 |
| 2017-12-31 | 0.35 |
| 2017-09-30 | 0.00 |
| 2017-06-30 | 0.00 |
| 2017-03-31 | 0.00 |
